drugset / Trial / NCT03809182
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study investigated the effect of dexmedetomidine in obese patients undergoing bariatric surgery.
Timeline
- Start
- 2012-09-27
- Primary completion
- 2013-07-25
- Completion
- 2013-07-25
Outcome
Mixed primary results
registry analysis (superiority test); Dexmedetomidine vs 0.9% Sodium-chloride; p = 0.38; Mixed Models Analysis NCT03809182 ↗
registry analysis (superiority test); Dexmedetomidine vs 0.9% Sodium-chloride; p = 0.02; Mixed Models Analysis NCT03809182 ↗
registry MEAN Dexmedetomidine: Hour 12 (T6): 16.6 (Standard Deviation 9.2) uU/dl NCT03809182 ↗
registry MEAN 0.9% Sodium-chloride: Hour 12 (T6): 25.9 (Standard Deviation 18.3) uU/dl NCT03809182 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | — |
| Background | Fentanyl | Other / unclassified | 1 ug/kg | — |
| Background | Morphine | Other / unclassified | 3 mg | Intravenous |